MUMBAI, India, April 9, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ); (and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated ...
Sandoz has gained the in-licensing of commercial distribution rights to the brand and authorized generic of respiratory inhalation medicine Proventil HFA (albuterol sulfate) Inhalation Aerosol from ...
MUMBAI: Shares of pharmaceutical major Cipla Ltd on Thursday gained as much as 16%, after the company received approval from the US Food and Drug Administration (USFDA) for its generic version of ...
A first generic of a commonly used albuterol inhaler is now available to treat or prevent bronchospasm. The Food and Drug Administration has cleared Cipla’s generic Proventil HFA (albuterol sulfate) ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Food and Drug Administration has approved the first Proventil HFA (albuterol sulfate) ...
The first generic albuterol inhaler in the United States was approved Wednesday by the U.S. Food and Drug Administration in response to inhaler shortages caused by the coronavirus pandemic. The ...
A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". DUBLIN, April 5, 2019 /CNW/ -- Endo International plc (NASDAQ: ENDP) ...
The product is indicated for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. The Food and Drug ...
(Reuters) - The U.S Food and Drug Administration on Wednesday approved reut.rs/2RnpE3h first generic of a commonly used albuterol sulfate-based inhaler, catering to increased demand from COVID-19 ...
DUBLIN, April 5, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results